Company / Return on Equity (ROE)
Guardant Health, Inc. Return on Equity (ROE) History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-302.1%
FY2023
5-year range
-1087.7% / -59.7%
FY2019-FY2023
Trend
+72.2%
vs FY2022
Sector context
#148 of 147
Health Care
What the data says
Guardant Health, Inc. reports negative total equity of -302.1% in FY2023. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-302.1% in FY2023 with a 5-year CAGR of -284.7%.
Declined from -59.7% to -302.1% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -283.2pp
- 5-Year Change
- -284.7pp
- 10-Year Change
- -
Sector benchmark
Bottom -1% in Health CareTop 101% of 147This company -302.1% Sector average -3.1%
▼
-9581.9% below sector average
Key checks
Key Insights
- In FY2023, return on equity (roe) increased 72.2% year-over-year.
- Currently 299.0pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2019.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -302.1% | +72.2% |
| FY2022 | -1087.7% | -1723.5% |
| FY2021 | -59.7% | -214.4% |
| FY2020 | -19.0% | -100.1% |
| FY2019 | -9.5% | +45.6% |
| FY2018 | -17.4% | +35.3% |
| FY2017 | -27.0% | +53.4% |
| FY2016 | -57.9% | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026